Akso Health GroupAHGEarnings & Financial Report
Nasdaq · Industrials · Services-Business Services, NEC
Akso Health Group is a global healthcare enterprise specializing in the R&D, production, and distribution of generic pharmaceuticals, over-the-counter wellness products, and medical devices. It primarily serves markets in China, Southeast Asia, and North America, with core business segments covering drug manufacturing, medical supply chains, and community healthcare services.
AHG Q2 FY2026 Key Financial Metrics
Revenue
$7.0M
Gross Profit
$622.8K
Operating Profit
$-1.4M
Net Profit
$-1.3M
Gross Margin
8.9%
Operating Margin
-20.5%
Net Margin
-18.6%
YoY Growth
N/A
Akso Health Group Q2 FY2026 Financial Summary
Akso Health Group reported revenue of $7.0M for Q2 FY2026, with a net profit of $-1.3M (-18.6% margin). Cost of goods sold was $6.4M, operating expenses totaled $2.1M.
Key Financial Metrics
| Total Revenue | $7.0M |
|---|---|
| Net Profit | $-1.3M |
| Gross Margin | 8.9% |
| Operating Margin | -20.5% |
| Report Period | Q2 FY2026 |
Income Statement
| Q2 2026 | |
|---|---|
| Revenue | $7.0M |
| YoY Growth | N/A |
Balance Sheet
| Q2 2026 | |
|---|---|
| Assets | $212.0M |
| Liabilities | $13.7M |
| Equity | $198.3M |
Cash Flow
| Q2 2026 | |
|---|---|
| Operating CF | $1.2M |